capital raising, page-90

Assuming the rumours are correct...

Factoring in the extra 50m shares i get the following EPS by year:
- 2012 9c (pro rata)
- 2013 10c
- 2014 17c
- 2015 17c

So a dividend of between 9 and 17c but the share price is 27c? I tip the share price to rise on monday.

THat said, we need to know what % of the Fonda earnings will be returned. I have assumed a) 100% of NPAT is paid out and b) annual burn of 1m ( maybe a little low).

And Oncology pricing would be interesting. I imagine they will wait until they have further good data from the SCLC trial before making the split. Maybe even some proof that HA-Iri kills cancer stem cells. That would change the value of the Oncology significantly i would think.